Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > I have to say I am upset, 10 million seems too much in 2024,
View:
Post by managementfirst on Jun 14, 2024 9:22am

I have to say I am upset, 10 million seems too much in 2024,

I feel that they are not confident to get BTD this year, this is why they need so much fund.
Comment by plantrader on Jun 14, 2024 9:27am
Could be, or it could be that they finally want to start progressing on some of the other indications. Maybe specifically because they see that being a one trick pony is not working out very well so far. Counting on BTD being the launching pad for all things has been the opposite of fruitful so far.
Comment by Lesalpes29 on Jun 14, 2024 9:44am
I recieved the e-mail yesterday but can't see the 10M they are willing to raise. We have to call them to know it?
Comment by CAinPlap on Jun 14, 2024 10:01am
Thank you for your ongoing support.   Theralase® has commenced a non brokered private placement to raise up to $CAN 10 M to close on or about Friday, June 21st, 2024. Please see below and attached for details of the private placement.    The private placement will be completed through Units of the Company (“Units”) at a cost of $CAN 0.22 per Unit.   Each Unit ...more  
Comment by Lesalpes29 on Jun 14, 2024 10:02am
Thank you. Hope they have a big boy interested!
Comment by StevenBirch on Jun 14, 2024 11:00am
It would be nice if they raise what they can and have someone to fill the balance, at least it's only a week away.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250